In this photo illustration, the American multinational pharmaceutical company Merck logo seen displayed on a smartphone with a computer model of the novel coronavirus on the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket vi Merck is giving up on two potential COVID-19 vaccines following poor results in early-stage studies.The drugmaker said Monday that it will focus instead on studying two possible treatments for the virus that also have yet to be approved by regulators.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.